Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

NCT00002657

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +37 more
Locations: MBCCOP - University of South Alabama Mobile, Alabama, United States

CCOP - Greater Phoenix Phoenix, Arizona, United States

Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States

Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States

View all 86 locations

View Trial Details

Completed

S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00003784

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: MBCCOP - University of South Alabama Mobile, Alabama, United States

CCOP - Greater Phoenix Phoenix, Arizona, United States

Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States

Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States

View all 87 locations

View Trial Details

Completed

Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00006473

Conditions: Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +57 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

NCT00005805

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

NCT00008359

Conditions: Adnexal Diseases, Agranulocytosis, Amyloidosis, +141 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Efficacy of Bortezomib (Velcade(R)) in Patients With Advanced Waldenström Macroglobulinemia

NCT00777738

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Hopital La Pitie Salpetriere Paris, France

View Trial Details

Completed

Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00047203

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type

NCT00190411

Conditions: Aneurysm, Aortic Dissection, CHROMOSOME 2q31.2 DELETION SYNDROME, +20 more
Locations: Not specified

View Trial Details

Completed

Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis

NCT00089167

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors

NCT00028821

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Hemostatic Disorders

Hemostatic Disorders trial results

Related conditions